Lars Erik Kristensen

University of Copenhagen — Denmark

Medicine · Health Sciences

36h-index5.5kcitations199works20.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Spondyloarthritis Studies and Treatments(99), Rheumatoid Arthritis Research and Therapies(78), Psoriasis: Treatment and Pathogenesis(78), Autoimmune and Inflammatory Disorders Research(38), Fibromyalgia and Chronic Fatigue Syndrome Research(18)

Publications199 total

POS0233 TRANSLATIONAL REMODELLING AND AMIDE METABOLIC DYSREGULATION DIFFERENTIATE MTX RESPONDERS AND NONRESPONDERS IN PSORIATIC ARTHRITIS – A SINGLE CELL PERSPECTIVE
Annals of the Rheumatic Diseases·2025Open Access
OP0223 THE EFFECT OF WEIGHT LOSS AND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST ON STRUCTURAL CHANGES IN KNEE OSTEOARTHRITIS: SECONDARY ANALYSIS OF THE RANDOMISED, PLACEBO-CONTROLLED LOSEIT TRIAL
Annals of the Rheumatic Diseases·2025Open Access
E098 Effectiveness of ixekizumab at 12 weeks in b/tsDMARD treatment-naive and experienced patients with psoriatic arthritis: PRO-SPIRIT study data
Lara D. Veeken·2025Open Access
COGNITIVE BIAS AND HEURISTICS ARE ASSOCIATED WITH IMPROVEMENT IN KNEE PAIN IN PATIENTS WITH KNEE OSTEOARTHRITIS TREATED WITH OPEN LABEL PLACEBO
Osteoarthritis and Cartilage·2025
Single-cell RNA sequencing highlights the influence of innate and adaptive immune response mechanisms in psoriatic arthritis
Frontiers in Immunology·2025· 3 citedOpen Access
Do cognitive bias and heuristics influence improvement in knee pain in patients with knee osteoarthritis treated with open label placebo? The CHIPS study - An exploratory study using questionnaire and group concept mapping
Osteoarthritis and Cartilage Open·2025Open Access
THE EFFECT OF WEIGHT LOSS AND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST ON STRUCTURAL CHANGES IN KNEE OSTEOARTHRITIS: SECONDARY ANALYSIS OF THE RANDOMISED, PLACEBO-CONTROLLED LOSEIT TRIAL
Osteoarthritis Imaging·2025Open Access
Les schémas thérapeutiques en vie réelle reflètent-ils les recommandations pour le rhumatisme psoriasique ? Résultats de l’étude PRO-SPIRIT
Revue du Rhumatisme·2024
Efficacité du baricitinib vs d’autres ts/bDMARD pour atteindre une faible activité de la maladie/rémission précoce jusqu’à 2 ans : étude RA-BE REAL chez des patients européens
Revue du Rhumatisme·2024
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis
New England Journal of Medicine·2024· 248 cited
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
Rheumatology and Therapy·2024· 2 citedOpen Access
Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52‐Week Results From Two Phase 3 Studies
ACR Open Rheumatology·2024· 2 citedOpen Access
The impact of an illness perception conversation on open-label placebo response in knee osteoarthritis: A randomised controlled trial
Osteoarthritis and Cartilage·2024· 3 citedOpen Access
Retention rate of a novel autoinjector e-Device introduced to patients with chronic arthritis treated with certolizumab pegol in clinical practice: an observational implementation study
Scandinavian Journal of Rheumatology·2024
POS0639 BENEFIT–RISK ANALYSIS OF UPADACITINIB VERSUS ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND HIGHER OR LOWER RISK OF CARDIOVASCULAR DISEASE
Annals of the Rheumatic Diseases·2024· 1 cited
AB0501 EFFECTIVENESS OF BARICITINIB VS OTHER TS/bDMARDs IN ACHIEVING EARLY LDA/REMISSION UP TO 2-YEARS: THE RA-BE-REAL STUDY IN EUROPEAN PATIENTS
Annals of the Rheumatic Diseases·2024
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data
Rheumatology and Therapy·2024· 5 citedOpen Access
Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials
Journal of Dermatological Treatment·2024· 4 citedOpen Access
THE IMPACT OF AN ILLNESS PERCEPTION CONVERSATION ON OPEN-LABEL PLACEBO RESPONSE IN KNEE OSTEOARTHRITIS: A RANDOMISED CONTROLLED TRIAL
Osteoarthritis and Cartilage·2024Open Access
P170 Ixekizumab significantly improved quality of life and joint pain in patients with psoriatic arthritis, nail disease and distal interphalangeal joint involvement from SPIRIT-H2H
Lara D. Veeken·2024Open Access
page 1 of 10Next →

Frequent Co-authors

Robin Christensen(14), Henning Bliddal(11), L. Jacobsson(11), Lene Dreyer(11), Pil Højgaard(9), Johan Askling(8), Tanja Schjødt Jørgensen(8), Johan K. Wallman(6), Merete Lund Hetland(5), Tore Saxne(5), Pierre Geborek(5), Ulf Lindström(5), Bente Glintborg(5), René Cordtz(5), Kristian Zobbe(5), Christine Ballegaard(5), Dafna D. Gladman(4), Laura C. Coates(4), Jørgen Guldberg–Møller(4), Philip J. Mease(4)